Connection

Dariusz Pytel to Colorectal Neoplasms

Back to Details
This is a "connection" page, showing publications Dariusz Pytel has written about Colorectal Neoplasms.
Dariusz Pytel
Connection Strength
0.366
Colorectal Neoplasms
  1. Small-molecule inhibitors of the PERK-mediated Unfolded Protein Response signaling pathway in targeted therapy for colorectal cancer. Pol Przegl Chir. 2022 Mar 15; 94(6):17-25.
    View in: PubMed
    Score: 0.143
  2. Use of Small-molecule Inhibitory Compound of PERK-dependent Signaling Pathway as a Promising Target-based Therapy for Colorectal Cancer. Curr Cancer Drug Targets. 2020; 20(3):223-238.
    View in: PubMed
    Score: 0.123
  3. Nucleotide Excision Repair Capacity and XPC and XPD Gene Polymorphism Modulate Colorectal Cancer Risk. Clin Colorectal Cancer. 2018 06; 17(2):e435-e441.
    View in: PubMed
    Score: 0.100
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.